Terminology Service for NFDI4Health
All individuals in FSKXO
| Label | Id | Description |
|---|---|---|
| ACT-15 | FSKXO_0000003485 | |
| ACT-16 | FSKXO_0000003486 | |
| ACT-17 | FSKXO_0000003487 | |
| ACT-18 | FSKXO_0000003488 | |
| ACT-19 | FSKXO_0000003489 | |
| ACT-2 | FSKXO_0000003490 | |
| ACT-3 | FSKXO_0000003491 | |
| ACT-4 | FSKXO_0000003492 | |
| ACT-5 | FSKXO_0000003493 | |
| ACT-6 | FSKXO_0000003494 | |
| ACT-7 | FSKXO_0000003495 | |
| ACT-8 | FSKXO_0000003496 | |
| ACT-9 | FSKXO_0000003497 | |
| AES | FSKXO_0000014294 | [Atomic emission spectroscopy and similar spectroscopy] |
| AFS | FSKXO_0000014295 | [Atomic fluorescence spectrometry] |
| AHD (1-aminohydantoin) | FSKXO_0000003522 | |
| AMOZ (5-methylmorpholino-3-amino-2-oxazolidone) | FSKXO_0000003633 | |
| AMPA | FSKXO_0000003634 | |
| AMPC phenotype | FSKXO_0000003635 | |
| AMS | FSKXO_0000014297 | [Accelerator mass spectrometry] |